TD Cowen says Spyre Therapeutics (SYRE)’ webcast “strengthened our confidence in an already great dataset” for SPY001, but adds that both managemen...
Source LinkTD Cowen says Spyre Therapeutics (SYRE)’ webcast “strengthened our confidence in an already great dataset” for SPY001, but adds that both managemen...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.